• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同类型毛细血管孔径的生理上限以及微血管通透性双孔理论的另一种观点。

Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability.

作者信息

Sarin Hemant

机构信息

National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

J Angiogenes Res. 2010 Aug 11;2:14. doi: 10.1186/2040-2384-2-14.

DOI:10.1186/2040-2384-2-14
PMID:20701757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2928191/
Abstract

BACKGROUND

Much of our current understanding of microvascular permeability is based on the findings of classic experimental studies of blood capillary permeability to various-sized lipid-insoluble endogenous and non-endogenous macromolecules. According to the classic small pore theory of microvascular permeability, which was formulated on the basis of the findings of studies on the transcapillary flow rates of various-sized systemically or regionally perfused endogenous macromolecules, transcapillary exchange across the capillary wall takes place through a single population of small pores that are approximately 6 nm in diameter; whereas, according to the dual pore theory of microvascular permeability, which was formulated on the basis of the findings of studies on the accumulation of various-sized systemically or regionally perfused non-endogenous macromolecules in the locoregional tissue lymphatic drainages, transcapillary exchange across the capillary wall also takes place through a separate population of large pores, or capillary leaks, that are between 24 and 60 nm in diameter. The classification of blood capillary types on the basis of differences in the physiologic upper limits of pore size to transvascular flow highlights the differences in the transcapillary exchange routes for the transvascular transport of endogenous and non-endogenous macromolecules across the capillary walls of different blood capillary types.

METHODS

The findings and published data of studies on capillary wall ultrastructure and capillary microvascular permeability to lipid-insoluble endogenous and non-endogenous molecules from the 1950s to date were reviewed. In this study, the blood capillary types in different tissues and organs were classified on the basis of the physiologic upper limits of pore size to the transvascular flow of lipid-insoluble molecules. Blood capillaries were classified as non-sinusoidal or sinusoidal on the basis of capillary wall basement membrane layer continuity or lack thereof. Non-sinusoidal blood capillaries were further sub-classified as non-fenestrated or fenestrated based on the absence or presence of endothelial cells with fenestrations. The sinusoidal blood capillaries of the liver, myeloid (red) bone marrow, and spleen were sub-classified as reticuloendothelial or non-reticuloendothelial based on the phago-endocytic capacity of the endothelial cells.

RESULTS

The physiologic upper limit of pore size for transvascular flow across capillary walls of non-sinusoidal non-fenestrated blood capillaries is less than 1 nm for those with interendothelial cell clefts lined with zona occludens junctions (i.e. brain and spinal cord), and approximately 5 nm for those with clefts lined with macula occludens junctions (i.e. skeletal muscle). The physiologic upper limit of pore size for transvascular flow across the capillary walls of non-sinusoidal fenestrated blood capillaries with diaphragmed fenestrae ranges between 6 and 12 nm (i.e. exocrine and endocrine glands); whereas, the physiologic upper limit of pore size for transvascular flow across the capillary walls of non-sinusoidal fenestrated capillaries with open 'non-diaphragmed' fenestrae is approximately 15 nm (kidney glomerulus). In the case of the sinusoidal reticuloendothelial blood capillaries of myeloid bone marrow, the transvascular transport of non-endogenous macromolecules larger than 5 nm into the bone marrow interstitial space takes place via reticuloendothelial cell-mediated phago-endocytosis and transvascular release, which is the case for systemic bone marrow imaging agents as large as 60 nm in diameter.

CONCLUSIONS

The physiologic upper limit of pore size in the capillary walls of most non-sinusoidal blood capillaries to the transcapillary passage of lipid-insoluble endogenous and non-endogenous macromolecules ranges between 5 and 12 nm. Therefore, macromolecules larger than the physiologic upper limits of pore size in the non-sinusoidal blood capillary types generally do not accumulate within the respective tissue interstitial spaces and their lymphatic drainages. In the case of reticuloendothelial sinusoidal blood capillaries of myeloid bone marrow, however, non-endogenous macromolecules as large as 60 nm in diameter can distribute into the bone marrow interstitial space via the phago-endocytic route, and then subsequently accumulate in the locoregional lymphatic drainages of tissues following absorption into the lymphatic drainage of periosteal fibrous tissues, which is the lymphatic drainage of myeloid bone marrow. When the ultrastructural basis for transcapillary exchange across the capillary walls of different capillary types is viewed in this light, it becomes evident that the physiologic evidence for the existence of aqueous large pores ranging between 24 and 60 nm in diameter in the capillary walls of blood capillaries, is circumstantial, at best.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4dc/2928191/57bab4c552d0/2040-2384-2-14-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4dc/2928191/57bab4c552d0/2040-2384-2-14-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4dc/2928191/57bab4c552d0/2040-2384-2-14-1.jpg
摘要

背景

我们目前对微血管通透性的许多理解是基于对毛细血管对各种大小的脂溶性内源性和非内源性大分子通透性的经典实验研究结果。根据基于对各种大小的全身或局部灌注内源性大分子跨毛细血管流速研究结果制定的经典微血管通透性小孔理论,跨毛细血管壁的跨毛细血管交换通过单一群体的直径约为6nm的小孔进行;而根据基于对各种大小的全身或局部灌注非内源性大分子在局部组织淋巴引流中积累的研究结果制定的微血管通透性双孔理论,跨毛细血管壁的跨毛细血管交换也通过另一群体的直径在24至60nm之间的大孔或毛细血管渗漏进行。基于跨血管流动的孔径生理上限差异对毛细血管类型进行分类,突出了内源性和非内源性大分子跨不同类型毛细血管壁进行跨血管运输的跨毛细血管交换途径的差异。

方法

回顾了20世纪50年代至今关于毛细血管壁超微结构以及毛细血管对脂溶性内源性和非内源性分子微血管通透性的研究结果和已发表数据。在本研究中,根据脂溶性分子跨血管流动的孔径生理上限对不同组织和器官中的毛细血管类型进行分类。根据毛细血管壁基底膜层的连续性与否,将毛细血管分为非窦状或窦状。非窦状毛细血管根据有无有窗孔的内皮细胞进一步细分为无窗孔或有窗孔。肝脏、骨髓(红)和脾脏的窦状毛细血管根据内皮细胞的吞噬内吞能力细分为网状内皮或非网状内皮。

结果

对于内皮细胞间裂由紧密连接排列的非窦状无窗孔毛细血管(即脑和脊髓),跨毛细血管壁跨血管流动的孔径生理上限小于1nm;对于裂由闭锁小带排列的(即骨骼肌),约为5nm。对于有隔膜窗孔的非窦状有窗孔毛细血管壁,跨血管流动的孔径生理上限在6至12nm之间(即外分泌和内分泌腺);而对于有开放“无隔膜”窗孔的非窦状有窗孔毛细血管壁,跨血管流动的孔径生理上限约为15nm(肾小球)。在骨髓的窦状网状内皮毛细血管中,大于5nm的非内源性大分子跨血管运输到骨髓间质空间是通过网状内皮细胞介导的吞噬内吞和跨血管释放进行的,直径达60nm的全身骨髓显像剂就是这种情况。

结论

大多数非窦状毛细血管壁对脂溶性内源性和非内源性大分子跨毛细血管通道的孔径生理上限在5至12nm之间。因此,大于非窦状毛细血管类型孔径生理上限的大分子通常不会在各自的组织间质空间及其淋巴引流中积累。然而,在骨髓的网状内皮窦状毛细血管中,直径达60nm的非内源性大分子可通过吞噬内吞途径分布到骨髓间质空间,然后在被骨膜纤维组织的淋巴引流(即骨髓的淋巴引流)吸收后,随后在局部组织淋巴引流中积累。当从这个角度看待不同类型毛细血管壁跨毛细血管交换的超微结构基础时,很明显,关于在毛细血管壁中存在直径在24至60nm之间的水性大孔的生理证据,充其量只是间接的。

相似文献

1
Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability.不同类型毛细血管孔径的生理上限以及微血管通透性双孔理论的另一种观点。
J Angiogenes Res. 2010 Aug 11;2:14. doi: 10.1186/2040-2384-2-14.
2
Anatomy, Lymphatic System解剖学,淋巴系统
3
On the future development of optimally-sized lipid-insoluble systemic therapies for CNS solid tumors and other neuropathologies.关于中枢神经系统实体瘤和其他神经病理学的最佳尺寸脂溶性全身疗法的未来发展。
Recent Pat CNS Drug Discov. 2010 Nov;5(3):239-52. doi: 10.2174/157488910793362403.
4
Transport of macromolecules across microvascular walls: the two-pore theory.大分子通过微血管壁的转运:双孔理论
Physiol Rev. 1994 Jan;74(1):163-219. doi: 10.1152/physrev.1994.74.1.163.
5
Physiological studies of macromolecular transport across capillary walls. Studies on continuous capillaries in rat skeletal muscle.大分子跨毛细血管壁转运的生理学研究。大鼠骨骼肌连续毛细血管的研究。
Acta Physiol Scand Suppl. 1986;553:1-40.
6
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors.恶性实体瘤血瘤屏障孔径的生理上限
J Transl Med. 2009 Jun 23;7:51. doi: 10.1186/1479-5876-7-51.
7
Fluid and protein fluxes across small and large pores in the microvasculature. Application of two-pore equations.微血管中小孔和大孔的液体及蛋白质通量。双孔方程的应用。
Acta Physiol Scand. 1987 Nov;131(3):411-28. doi: 10.1111/j.1748-1716.1987.tb08257.x.
8
[The significance of the veins for transcapillary fluid balance].[静脉对跨毛细血管液体平衡的意义]
Acta Med Austriaca. 1976;3(4):100-4.
9
[Capillary permeability and macromolecular exchange with special reference to structure of microvascular walls].[毛细血管通透性与大分子交换,特别涉及微血管壁的结构]
Nihon Rinsho. 2005 Jan;63(1):19-25.
10
Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability.疾病中的内皮糖萼功能障碍:白蛋白尿和微血管通透性增加。
J Pathol. 2012 Mar;226(4):562-74. doi: 10.1002/path.3964.

引用本文的文献

1
Enhanced Accumulation of Heteroduplex Oligonucleotides in Dystrophin-Deficient Skeletal Muscles by Single Oligonucleotide-Loaded Unit Polyion Complexes.单链寡核苷酸负载的单元聚离子复合物增强异源双链寡核苷酸在肌营养不良蛋白缺陷型骨骼肌中的积累
ACS Omega. 2025 Aug 1;10(31):34363-34371. doi: 10.1021/acsomega.5c02207. eCollection 2025 Aug 12.
2
Stimuli-Responsive Materials for Biomedical Applications.用于生物医学应用的刺激响应材料
Adv Mater. 2025 Sep;37(36):e07559. doi: 10.1002/adma.202507559. Epub 2025 Aug 13.
3
Overview of Preclinical and Clinical Trials of Nanoparticles for the Treatment of Brain Metastases.

本文引用的文献

1
Intercellular cement and capillary permeability.细胞间黏合质与毛细血管通透性
Physiol Rev. 1947 Jul;27(3):436-63. doi: 10.1152/physrev.1947.27.3.436.
2
Aquaporin-1 in blood vessels of rat circumventricular organs.血管中的水通道蛋白-1在大鼠室周器官。
Cell Tissue Res. 2010 Apr;340(1):159-68. doi: 10.1007/s00441-010-0927-2. Epub 2010 Feb 23.
3
Electrostatics of aquaporin and aquaglyceroporin channels correlates with their transport selectivity.水通道蛋白和甘油通道蛋白的静电特性与其转运选择性相关。
用于治疗脑转移瘤的纳米颗粒的临床前和临床试验概述。
Pharmaceutics. 2025 Jul 11;17(7):899. doi: 10.3390/pharmaceutics17070899.
4
Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases.用于治疗眼部疾病的基于纳米医学的眼科药物递送系统
Int J Nanomedicine. 2025 Jul 21;20:9221-9249. doi: 10.2147/IJN.S532074. eCollection 2025.
5
Obesity Alters the Vascular Morphology and VEGF-A Signaling in Adipose Tissue.肥胖改变脂肪组织中的血管形态和血管内皮生长因子A(VEGF-A)信号传导。
FASEB Bioadv. 2025 May 19;7(6):e70018. doi: 10.1096/fba.2025-00027. eCollection 2025 Jun.
6
How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport.高密度脂蛋白如何参与动脉粥样硬化形成?抗氧化活性与逆向胆固醇转运中的作用
Antioxidants (Basel). 2025 Apr 2;14(4):430. doi: 10.3390/antiox14040430.
7
Investigation of Radiotherapy along with Gemcitabine Loaded PEG Gold Nanoparticles Against MCF-7 Breast Cancer Cells.吉西他滨负载的聚乙二醇化金纳米颗粒联合放疗对MCF-7乳腺癌细胞的研究。
Adv Biomed Res. 2025 Feb 28;14:12. doi: 10.4103/abr.abr_221_24. eCollection 2025.
8
Recent strategies for enhanced delivery of mRNA to the lungs.近期增强mRNA肺部递送的策略。
Nanomedicine (Lond). 2025 May;20(9):1043-1069. doi: 10.1080/17435889.2025.2485669. Epub 2025 Apr 7.
9
Biodistribution of therapeutic extracellular vesicles.治疗性细胞外囊泡的生物分布。
Extracell Vesicles Circ Nucl Acids. 2023 Apr 19;4(2):170-190. doi: 10.20517/evcna.2023.12. eCollection 2023.
10
Molecular and Functional Characterization of the Peritoneal Mesothelium, a Barrier for Solute Transport.腹膜间皮的分子与功能特性:溶质转运的屏障
Function (Oxf). 2025 Feb 12;6(1). doi: 10.1093/function/zqae051.
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4135-40. doi: 10.1073/pnas.0910632107. Epub 2010 Feb 10.
4
Development of the human choriocapillaris.人绒毛细血管的发育。
Eye (Lond). 2010 Mar;24(3):408-15. doi: 10.1038/eye.2009.318. Epub 2010 Jan 15.
5
THE RENAL CLEARANCE OF HEMOGLOBIN IN THE DOG.血红蛋白在狗体内的肾清除率。
J Exp Med. 1940 Jul 31;72(2):149-65. doi: 10.1084/jem.72.2.149.
6
Stabilins are expressed in bone marrow sinusoidal endothelial cells and mediate scavenging and cell adhesive functions.稳定素在骨髓窦状内皮细胞中表达,并介导清除和细胞黏附功能。
Biochem Biophys Res Commun. 2009 Dec 18;390(3):883-6. doi: 10.1016/j.bbrc.2009.10.068. Epub 2009 Oct 20.
7
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors.恶性实体瘤血瘤屏障孔径的生理上限
J Transl Med. 2009 Jun 23;7:51. doi: 10.1186/1479-5876-7-51.
8
Developmental and pathogenic mechanisms of basement membrane assembly.基底膜组装的发育和致病机制。
Curr Pharm Des. 2009;15(12):1277-94. doi: 10.2174/138161209787846766.
9
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells.纳米颗粒通过血管有效递送穿过血脑肿瘤屏障进入恶性胶质瘤细胞。
J Transl Med. 2008 Dec 18;6:80. doi: 10.1186/1479-5876-6-80.
10
Effective osmotic pressure of the plasma proteins and other quantities associated with the capillary circulation in the hindlimbs of cats and dogs.猫和狗后肢血浆蛋白的有效渗透压及与毛细血管循环相关的其他量
Am J Physiol. 1948 Mar 1;152(3):471-91. doi: 10.1152/ajplegacy.1948.152.3.471.